Latest clinical updates | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Clinical

First EU approval for fulvestrant in combination with a CDK4/6 inhibitor

First EU approval for fulvestrant in combination with a CDK4/6 inhibitor

First Avastin biosimilar candidate recommended for European approval

First Avastin biosimilar candidate recommended for European approval

Positive CHMP opinion for letermovir in the European Union

Positive CHMP opinion for letermovir in the European Union

The importance of diagnostic procedures in ensuring healthcare quality

The importance of diagnostic procedures in ensuring healthcare quality

REPRISE trial presented at American Society of Nephrology Kidney Week 2017

REPRISE trial presented at American Society of Nephrology Kidney Week 2017

Efficacy and safety maintained in patients who switched from Humira to biosimilar

Efficacy and safety maintained in patients who switched from Humira to biosimilar

Monoclonal antibody shows positive results in treatment of SLE in Phase II trial

Monoclonal antibody shows positive results in treatment of SLE in Phase II trial

NHS England enters commercial agreement that allows MS patients immediate access to therapy

NHS England enters commercial agreement that allows MS patients immediate access to therapy

Survey underlines the importance of action on medicines to prevent patients being put at risk by Brexit

Survey underlines the importance of action on medicines to prevent patients being put at risk by Brexit

Full market release of rainbow acoustic monitoring sensor RAS-45

Full market release of rainbow acoustic monitoring sensor RAS-45

US release of Trace™ Data Visualisation and Reporting Tool

US release of Trace™ Data Visualisation and Reporting Tool

First major treatment advance in bladder cancer in three decades reimbursed for patient use

First major treatment advance in bladder cancer in three decades reimbursed for patient use

Symptom improvement in moderately to severely active Crohn’s disease with ustekinumab

Symptom improvement in moderately to severely active Crohn’s disease with ustekinumab

One-year results for biosimilar infliximab switching study in Crohn’s disease

One-year results for biosimilar infliximab switching study in Crohn’s disease

Point-of-care ultrasound invaluable for treatment of ICU patients

Point-of-care ultrasound invaluable for treatment of ICU patients

Newborn Foundation and Masimo partnership reaches 52,000 babies and 1000 health workers

Newborn Foundation and Masimo partnership reaches 52,000 babies and 1000 health workers

Positive opinion for abiraterone acetate to include earlier stage prostate cancer patients

Positive opinion for abiraterone acetate to include earlier stage prostate cancer patients

New hope for thyroid and parathyroid surgery using regional anaesthesia

New hope for thyroid and parathyroid surgery using regional anaesthesia

x